Advanced search
Add to list

COVID‐19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies

Jozefien Declercq (UGent) , Els Tobback (UGent) , Stijn Vanhee (UGent) , Natalie De Ruyck (UGent) , Sarah Gerlo (UGent) , Philippe Gevaert (UGent) and Linos Vandekerckhove (UGent)
Author
Organization
Keywords
Immunology, Immunology and Allergy

Citation

Please use this url to cite or link to this publication:

MLA
Declercq, Jozefien, et al. “COVID‐19 Vaccination with BNT162b2 and ChAdOx1 Vaccines Has the Potential to Induce Nasal Neutralizing Antibodies.” ALLERGY, 2021, doi:10.1111/all.15101.
APA
Declercq, J., Tobback, E., Vanhee, S., De Ruyck, N., Gerlo, S., Gevaert, P., & Vandekerckhove, L. (2021). COVID‐19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies. ALLERGY. https://doi.org/10.1111/all.15101
Chicago author-date
Declercq, Jozefien, Els Tobback, Stijn Vanhee, Natalie De Ruyck, Sarah Gerlo, Philippe Gevaert, and Linos Vandekerckhove. 2021. “COVID‐19 Vaccination with BNT162b2 and ChAdOx1 Vaccines Has the Potential to Induce Nasal Neutralizing Antibodies.” ALLERGY. https://doi.org/10.1111/all.15101.
Chicago author-date (all authors)
Declercq, Jozefien, Els Tobback, Stijn Vanhee, Natalie De Ruyck, Sarah Gerlo, Philippe Gevaert, and Linos Vandekerckhove. 2021. “COVID‐19 Vaccination with BNT162b2 and ChAdOx1 Vaccines Has the Potential to Induce Nasal Neutralizing Antibodies.” ALLERGY. doi:10.1111/all.15101.
Vancouver
1.
Declercq J, Tobback E, Vanhee S, De Ruyck N, Gerlo S, Gevaert P, et al. COVID‐19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies. ALLERGY. 2021;
IEEE
[1]
J. Declercq et al., “COVID‐19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies,” ALLERGY, 2021.
@article{8723040,
  author       = {{Declercq, Jozefien and Tobback, Els and Vanhee, Stijn and De Ruyck, Natalie and Gerlo, Sarah and Gevaert, Philippe and Vandekerckhove, Linos}},
  issn         = {{0105-4538}},
  journal      = {{ALLERGY}},
  keywords     = {{Immunology,Immunology and Allergy}},
  language     = {{eng}},
  pages        = {{3}},
  title        = {{COVID‐19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies}},
  url          = {{http://dx.doi.org/10.1111/all.15101}},
  year         = {{2021}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: